Explorer les evidences

6,4 %HBV prevalence was 6.4% (95% CI: 3.3–9.5%) among persons aged 45–54 years in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

6 %Genotype D accounted for 6% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublié 2023PLOS global public healtheurope_pmcdocument de 8 observations

13 %The seroprevalence of Hepatitis B infection among HIV infected persons was 13%.

Kenyahépatite B · VIH/sidapublié 2012The African Journal of Pharmacology and TherapeuticsOpenAlexdocument de 2 observations

3 %HBV prevalence among persons aged 15–64 years in Kenya was 3.0%.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

8,8 %Of 859 participants who were never infected with HBV, 60 (8.8%) had anti-HBs titers >10 IU/L, indicating immunity due to vaccination.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

5,3 %Among 208 HIV-infected ART-naïve adults in Kenya, 11 (5.3%) had occult hepatitis B virus (OBI) infection.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

10,1 %The prevalence of HBsAg positivity was 10.1% among 99 male sex workers in Nairobi.

Kenyahépatite Bpublié 2020PloS onePubMeddocument de 2 observations

95,7 %Among 208 HIV-infected ART-naïve adults in Kenya, 199 (95.7%) did not report hepatitis B virus (HBV) vaccination.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

4,9 %HBV prevalence by site was: Entebbe (4.9%), Kampala (4.1%), and Nairobi (0.3%).

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

28,5 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 28.5% had past HBV infection.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

3 %The weighted national HBV prevalence was 3.0% (95% CI: 2.2–3.9%).

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

6,1 %Pooled HBV prevalence was 6.1% in the moderate-risk group.

Kenyahépatite Bpublié 2023PLOS global public healtheurope_pmcdocument de 8 observations

0,51 aorThe odds of never being HBV infected were lower among older individuals aged 25–29 years (adjusted odds ratio 0.51).

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

3 %HBV prevalence was 3.0% (95% CI: 2.1–3.9%) among HIV-negative persons in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

1,3 %Among 3152 participants who inject drugs in Kenya, 40 (1.3%) were HBV-positive.

Kenyahépatite Bpublié 2025The International journal on drug policyPubMeddocument de 6 observations

2,21 aorThe odds of never being HBV infected were higher among participants with informal high-risk jobs from Kampala (adjusted odds ratio 2.21) compared to those from Entebbe.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

2,61 aorThe odds of never being HBV infected were higher among participants with informal high-risk jobs from Nairobi (adjusted odds ratio 2.61) compared to those from Entebbe.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

258 patientsA total of 258 patients participated in the study, with 129 HIV mono-infected (controls) and 129 HIV/HBV co-infected (cases).

Kenyahépatite B · VIH/sidapublié 2021Pan African Medical JournalOpenAlexdocument de 10 observations

67,9 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 67.9% were never infected with HBV.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

92 %Genotype A accounted for 92% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublié 2023PLOS global public healtheurope_pmcdocument de 8 observations

7,8 %The overall pooled prevalence estimate of Hepatitis B virus infection in Kenya was 7.8%.

Kenyahépatite Bpublié 2023Frontiers in public healthPubMeddocument de 6 observations

810 600 inhabitantsThe HBV infection burden was estimated at 810,600 persons aged 15–64 years in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

Hepatitis B coinfection was observed at similar rates in both the AFRICOS and DC Cohort samples.

Kenyahépatite Bpublié 2022PloS onePubMeddocument de 13 observations

57,2 %Among 208 HIV-infected ART-naïve adults in Kenya, 119 (57.2%) had no hepatitis B virus (HBV) markers.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

10,7 %HBV prevalence was 10.7% (95% CI: 5.1–16.4%) among persons who reported no formal education in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations